2026 NPPES data Specialist NPI 1154582542 M.D.
Verify on CMS →

Mohammad Alfarawati, M.D.

Specialist in Mount Pleasant, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,658 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
406
Medicare Part D claims · 109 beneficiaries · Specialist avg: 1K
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$374.11
16 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Mohammad Alfarawati, M.D. filed 406 Medicare Part D claims in 2023 as a Specialist in Mount Pleasant, Texas, prescribing 65% generic.

406
Part D claims, 2023
65%
generic prescribing
$374.11
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Mohammad Alfarawati, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

406 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Mohammad Alfarawati, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/19/2008

NPI 1154582542

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

406 72% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in Texas

How Specialist compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Specialist - 0.6%Specialist0.6%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Specialist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Mohammad Alfarawati, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 2001 N JEFFERSON AVE STE 130, Mount Pleasant, TX, 75455, with a listed phone of (903) 434-4826. NPI 1154582542 was issued on 06/19/2008.

Medicare Part D records for calendar year 2023 show 406 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $143K in drug spend, split 35% brand-name and 65% generic by claim count.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2001 N JEFFERSON AVE STE 130
Mount Pleasant, TX 75455

Provider Details

NPI 1154582542
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 06/19/2008

Hospital and facility affiliations

Facilities where Mohammad Alfarawati, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Titus County Hospital District
Mount Pleasant, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mohammad Alfarawati, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$374

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Mohammad Alfarawati, M.D.. To verify Mohammad Alfarawati, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Mohammad Alfarawati, M.D. - brand share 35.0%
Specialist average

35% brand-name claims vs 65% generic, on 406 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

406
Total Claims
$143K
Total Drug Cost
109
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
479
Total Day Supply
11,569
Brand vs Generic
35% brand / 65% generic
Brand Drug Cost
$133K
Generic Drug Cost
$10K
Antibiotic Claims
59

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
1.46
Gender Split
67% female / 33% male
Age Distribution
<65: 19, 65-74: 53, 75-84: 26, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Mohammad Alfarawati, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
84
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
76
Roflumilast
29
Symbicort
Budesonide/Formoterol Fumarate
29
Montelukast Sodium
28
Azithromycin
16
Doxycycline Hyclate
16
Levofloxacin
13
Albuterol Sulfate Hfa
Albuterol Sulfate
11
Furosemide
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How Mohammad Alfarawati, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

Mohammad Alfarawati, M.D.'s 406 claims are below the specialty average of 1,474.

Nearby Specialist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Alfarawati.

Compare Specialist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Mohammad Alfarawati, M.D.'s specialty?
Mohammad Alfarawati, M.D. specializes in Specialist and practices in Mount Pleasant, Texas. Credentials: M.D..
How much does Mohammad Alfarawati, M.D. prescribe under Medicare Part D?
In 2023, Mohammad Alfarawati, M.D. wrote 406 Medicare Part D claims totaling $143K in drug costs for 109 beneficiaries.
Where is Mohammad Alfarawati, M.D. located?
Mohammad Alfarawati, M.D. is located at 2001 N JEFFERSON AVE STE 130, Mount Pleasant, TX, 75455. Phone: (903) 434-4826.
What is Mohammad Alfarawati, M.D.'s NPI number?
Mohammad Alfarawati, M.D.'s National Provider Identifier (NPI) is 1154582542, issued on 06/19/2008.
Does Mohammad Alfarawati, M.D. prescribe more brand-name or generic drugs?
Mohammad Alfarawati, M.D.'s prescribing is 35% brand-name and 65% generic drugs by claim count, with $133K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does Mohammad Alfarawati, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Mohammad Alfarawati, M.D.'s most frequently prescribed drugs include Prednisone, Trelegy Ellipta, Roflumilast. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mohammad Alfarawati, M.D. accept Medicare?
Mohammad Alfarawati, M.D. appears in CMS Medicare data with 406 Part D claims and 109 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mohammad Alfarawati, M.D.'s credentials?
Mohammad Alfarawati, M.D.'s NPI is 1154582542 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.